The SURPASS and SURMOUNT programs collectively demonstrate tirzepatide as a transformative therapy for cardiometabolic disease
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
The condition is reversible through consistent hydration, electrolyte management, and slower postural transitions
Attempting to split doses without pharmacy guidance risks altering the medication's stability and sterility, potentially compromising both safety and effectiveness
Since these medications slow down gastric emptying, consuming fatty foods can exacerbate feelings of nausea and bloating
The most common side effects of tirzepatide are gastrointestinal, including nausea, vomiting, diarrhea, and decreased appetite